Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Comparative integromics on Eph family.

Masuko Katoh¹, Masaru Katoh

¹M&M Medical BioInformatics, Hongo 113-0033, Japan.

International Journal of Oncology

|April 6, 2006

Summary

The EPH family receptor A7 (EPHA7) gene is linked to the WNT signaling pathway. Its promoter contains binding sites conserved across species, suggesting a role in development and disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Frontiers in molecular medicine·2025

Same author

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

International journal of molecular medicine·2024

Same author

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Frontiers in molecular medicine·2024

Same author

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Clinical and translational medicine·2024

Same author

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Nature reviews. Clinical oncology·2024

Same author

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Scientific reports·2024

Area of Science:

Molecular Biology
Genetics
Developmental Biology
Systems Medicine

Background:

Ephrin/EPH signaling pathways interact with WNT signaling during crucial biological processes like embryogenesis, tissue regeneration, and cancer development.
The EPH family, including EPHA7, comprises receptors for Ephrin ligands, playing significant roles in cellular communication.

Purpose of the Study:

To investigate the presence of TCF/LEF-binding sites in the promoter regions of human EPH family members.
To perform comparative genomics on EPHA7 orthologs to understand evolutionary conservation of regulatory elements.
To explore the potential role of EPHA7 in human diseases and its implications for systems medicine.

Main Methods:

Bioinformatic analysis and human intelligence were employed to identify TCF/LEF-binding sites in EPH gene promoters.
Comparative genomics was used to analyze EPHA7 orthologs across different species.
Analysis of gene expression patterns in various human and mouse tissues and tumors.

Main Results:

Five TCF/LEF-binding sites were identified in the 5'-promoter region of the human EPHA7 gene.
EPHA7 orthologs in primates and cows showed conserved TCF/LEF-binding sites, indicating evolutionary conservation as WNT/beta-catenin signaling targets.
EPHA7 expression was detected in embryonic stem cells, neural tissues, and various tumors; deletions and hypermethylation were observed in human cancers.

Conclusions:

The EPHA7 gene is a conserved target of the WNT/beta-catenin signaling pathway, with regulatory elements present in primates and cows but not mice.
Alterations in EPHA7, such as deletion and promoter CpG hypermethylation, may contribute to its down-regulation in human tumors.
EPHA7 holds potential as a target for systems medicine, particularly in regenerative medicine and oncology.

Related Experiment Videos